Marvell Technology Stock Price Forecast: Morgan Stanley Says Selloff Overdone, Stock Poised to Rebound at $163
AI Podcast
Marvell Technology shares fell over 30% following its acquisition of Lumentum, closing at $171.41 on November 2 amid concerns over high costs and equity dilution. However, Morgan Stanley views the sell-off as excessive, maintaining an “Equal-Weight” rating and a $300 target price. The merger combines Marvell’s custom chips with Lumentum’s laser manufacturing, enhancing AI optical solutions. Key risks include potential customer churn and profit margin pressures from laser price drops. Technically, the stock is approaching support at the late-July low of $162.90; holding this level could trigger a rebound toward the $192.50 resistance zone, while a breakdown would reinforce bearish momentum.
TradingKey - After Marvell Technology (MRVL) announced its acquisition of Lumentum (LITE), the stock has experienced a cumulative pullback of over 30%, closing at $171.41 on November 2. High acquisition costs, equity dilution, and a lengthy closing timeline have rattled investors, but Morgan Stanley believes the market sell-off may be overdone.
Morgan Stanley notes that Marvell's strengths are concentrated in digital signal processors, switch chips, and custom chips, while Lumentum possesses scarce laser manufacturing capabilities. Post-merger, the two companies can jointly design light sources and chips, shortening customer qualification cycles and increasing the proprietary product value per optical connection. The acquisition also helps secure critical laser supplies. As AI data center customers transition toward more integrated optical communications solutions, Marvell will have the opportunity to win orders with a more comprehensive product portfolio.
The firm also pointed out that tight laser supply has driven its profitability above its previous long-term targets. If new capacity causes prices to fall, profits could fall short of expectations implied by the deal pricing, even with revenue growth. Additionally, some of Marvell's current DSP customers are competitors of Lumentum, and the risk of post-merger customer churn could offset synergy gains.
Overall, Morgan Stanley believes the market sell-off is overdone, maintaining its "Equal-Weight" rating and a target price of $300.
From a technical perspective, Marvell is currently in a downward probe following consecutive breakdowns. The stock has broken below the 0.786 Fibonacci retracement level (around $192.5) and is approaching its previous low from late July ($162.90). The key focus now is whether this historical low can offer support.
Although the stock recovered slightly from intraday lows, a clear bottoming structure has yet to form. The recent decline has broken below the previous consolidation range, and a narrowing loss in a single candlestick is insufficient to signal the end of the adjustment.
Marvell daily stock price chart, Source: TradingView
Although short-term moving averages are diverging downward and the short-term trend remains weak, the 80-day exponential moving average is slightly above the 160-day exponential moving average, 160-day exponential moving average.
The primary support below lies at the late-July low ($162.90). If the stock holds above this level, it may initiate a technical rebound, with target prices in the $192.5–$193.46 resistance zone formed by the 0.786 Fibonacci retracement level and the 5-day exponential moving average. If the stock falls below $162.90 and fails to reclaim it on a pullback, the downward structure will be further reinforced.
This content was translated using AI and reviewed for clarity. It is for informational purposes only.
Recommended Articles
Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.